The vaccine was administered only in women, since HPV is responsible for about 90% of cases of cancer of the cervix
The National Agency for Sanitary Vigilance Agency (Anvisa) released the implementation of HPV vaccine in men, 9 to 26 years. Until then, the vaccine was being applied only in women, as a means of preventing cervical cancer, since HPV is responsible for about 90% of cases.
According Anvisa, new studies have proven the effectiveness of the vaccine also in males. Immunization, however, is not yet available in the public health system, only in private clinics.
HPV, abbreviation for human papilloma virus, is transmitted by genital contact with an infected person (including oral sex) and by blood, from mother to child during childbirth. In most cases, the infection is transient and disappears without a trace.
The Ministry of Health indicate that HPV is a sexually transmitted diseases (STDs) common in the world. One in five women are carrying the virus. In Brazil, 137,000 new cases are reported each year.
Source: http://www.isaude.net
0 comments:
Post a Comment